Your browser is no longer supported. Please, upgrade your browser.
Settings
GSK GlaxoSmithKline plc daily Stock Chart
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E249.47 EPS (ttm)0.15 Insider Own0.20% Shs Outstand2.43B Perf Week-1.62%
Market Cap91.63B Forward P/E13.66 EPS next Y2.76 Insider Trans0.00% Shs Float2.41B Perf Month-2.76%
Income379.00M PEG21.23 EPS next Q0.63 Inst Own9.10% Short Float0.32% Perf Quarter-13.36%
Sales33.48B P/S2.74 EPS this Y204.10% Inst Trans-1.61% Short Ratio2.16 Perf Half Y-9.73%
Book/sh0.07 P/B538.14 EPS next Y7.15% ROA0.50% Target Price48.25 Perf Year0.07%
Cash/sh2.43 P/C15.49 EPS next 5Y11.75% ROE13.90% 52W Range35.49 - 44.54 Perf YTD-0.13%
Dividend1.86 P/FCF- EPS past 5Y40.20% ROI41.40% 52W High-15.43% Beta0.89
Dividend %4.94% Quick Ratio0.70 Sales past 5Y-3.40% Gross Margin67.00% 52W Low6.13% ATR0.54
Employees101192 Current Ratio1.00 Sales Q/Q23.10% Oper. Margin6.60% RSI (14)35.95 Volatility0.87% 1.11%
OptionableYes Debt/Eq140.27 EPS Q/Q49.60% Profit Margin1.10% Rel Volume1.08 Prev Close37.70
ShortableYes LT Debt/Eq111.57 EarningsOct 26 Payout- Avg Volume3.54M Price37.67
Recom2.00 SMA20-2.37% SMA50-6.37% SMA200-8.23% Volume3,821,295 Change-0.08%
Oct-20-16Initiated Investec Buy
Sep-23-16Initiated Piper Jaffray Overweight
Jul-14-16Upgrade Jefferies Hold → Buy
Mar-30-16Upgrade Citigroup Neutral → Buy
Feb-26-16Initiated Cantor Fitzgerald Hold
Dec-09-15Upgrade BofA/Merrill Neutral → Buy
Dec-07-15Reiterated Argus Buy $52 → $48
Oct-20-15Upgrade Credit Suisse Underperform → Neutral
Sep-15-15Upgrade Exane BNP Paribas Underperform → Neutral
Sep-08-15Upgrade BofA/Merrill Underperform → Neutral
Jun-26-15Upgrade Liberum Sell → Hold
Jun-04-15Downgrade Morgan Stanley Overweight → Equal-Weight
May-20-15Resumed Citigroup Neutral
Apr-15-15Initiated Societe Generale Sell
Feb-19-15Reiterated Argus Buy $55 → $52
Aug-08-14Reiterated Argus Buy $65 → $55
Apr-23-14Upgrade Argus Hold → Buy
May-28-13Upgrade Deutsche Bank Hold → Buy
Jan-11-11Upgrade Jefferies Hold → Buy
Jun-02-10Upgrade Jefferies Hold → Buy
Dec-05-16 10:33AM  Robust Pipeline Supports 5.5% Dividend Yield
09:36AM  GSK insider Waterhouse to head drugmaker's HIV unit ViiV
07:30AM  Adaptimmune Announces Initiation of Myxoid/Round Cell Liposarcoma Study GlobeNewswire
Dec-04-16 05:08PM  What Smart Money Thinks About GlaxoSmithKline plc (ADR) (GSK) at Insider Monkey
Dec-02-16 02:59PM  How to Buy GlaxoSmithKline at a 15% Discount
01:26PM  GlaxoSmithKline PLC (ADR) (GSK) Wins Approval Of Its Asthma Drug Nucala at Insider Monkey
11:27AM  Glaxo and Innoviva Get Positive News (GSK, INVA) at Investopedia
11:23AM  How China Makes Money (BABA, PFE) at Investopedia
09:15AM  GSK Files Regulatory Submission in European Union for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD Business Wire
02:00AM  Relvar® Ellipta® 100/25 mcg Gains Approval in Japan for Use in Patients with COPD Business Wire
Dec-01-16 04:48PM  Here's the Best Dividend Stock in Big Pharma at Motley Fool
08:04AM  AbbVie Is Focused on Growth Opportunities in Neuroscience Space
Nov-30-16 12:56PM  GlaxoSmithKline PLC (ADR) (GSK) Targeting Blockbuster Sales With Shingles Vaccine On EU Approval at Insider Monkey
Nov-29-16 04:00PM  GlaxoSmithKline Plans Nigeria Health Boost After Drinks Sale at Bloomberg
10:35AM  Should You Buy 3M Co (MMM)? at Insider Monkey
09:17AM  Injections, implants tested as new weapons to prevent HIV
07:00AM  [$$] Pharma giants see future of lower healthcare profits at Financial Times
07:00AM  [$$] Big data promise exponential change in healthcare at Financial Times
Nov-28-16 08:29AM  Glaxo (GSK) Files Regulatory Application for Shingrix in EU
Nov-25-16 11:33AM  GlaxoSmithKline Studies EPO-Like Anemia Drug (GSK) at Investopedia
Nov-24-16 08:11AM  Glaxo Nucala Favorable in Rare Vasculitis Disease Study
07:13AM  GSK chases Astra with start of big anaemia drug trials Reuters
Nov-23-16 11:20AM  Smart Money Continues to Lose Confidence In McDonalds Corporation (MCD) at Insider Monkey
08:41AM  5 Very Safe Dividend Stocks to Buy Now and Hold Forever at 24/7 Wall St.
Nov-22-16 06:30PM  6 Worthy Dividend Stocks Down 10% or More
03:56PM  GlaxoSmithKline Seeks FDA OK for COPD Inhaler (GSK) at Investopedia
09:49AM  Heres Our Take On Theravance Biopharma Inc (TBPH) And GlaxoSmithKline PLC (ADR) (GSK)s Latest Submission at Insider Monkey
09:00AM  Glaxo Files for COPD Drug; FluLaval Approved for Infants
08:15AM  Blog Coverage GlaxoSmithKline Files for US Approval for Triple Combination Lung Cancer Therapy Accesswire
Nov-21-16 05:04PM  Copaxone May Face Competitive Pressures in the Future
02:04PM  2 Excellent Dividend-Paying Drug Stocks to Add to Your Portfolio
11:15AM  GSK seeking FDA approval for 'triple combination' COPD therapy at bizjournals.com
08:28AM  GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older PR Newswire
07:00AM  GSK files regulatory submission in US for once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD PR Newswire
03:00AM  GlaxoSmithKline seeks U.S. approval for triple lung drug Reuters
02:00AM  GSK Files Regulatory Submission in US for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD Business Wire
Nov-18-16 10:04AM  Innovative Research in Vaccines May Boost Pfizers Revenues
08:16AM  Better Buy: AbbVie Inc. vs. GlaxoSmithKline PLC at Motley Fool
Nov-17-16 10:51PM  Glaxo (GSK) Presents Phase III Data on Sirukumab & Benlysta
11:04AM  How Sandoz Performed for Novartis in 3Q16
Nov-16-16 05:04PM  Novartiss 3Q16 Earnings Surpass Analyst Estimates
11:31AM  Ex-sleuths sue GlaxoSmithKline over imprisonment in China
Nov-15-16 10:50AM  Sanofi, GSK expect further price pressure, more M&A under Trump Reuters
Nov-14-16 11:02AM  New Phase IV Data On VBI Vaccines, Inc. (VBIV) HBV Vaccine Show It Can Carve Out A Market From GlaxoSmithKline PLC (ADR) (GSK) at Insider Monkey
08:04AM  The Performance of AstraZenecas Growth Platforms in 3Q16
Nov-13-16 09:28PM  New Pharma Rankings On Global Access To Medicine Released at Forbes
Nov-11-16 02:09PM  A massive nonprofit rejected a bunch of donated vaccines from Pfizer and now the drug giant is offering them at a lower price
06:17AM  Pfizer offers cut-price pneumonia shot for humanitarian crises Reuters
Nov-10-16 12:04PM  Here's Which Pharma Giants Might Want to Buy Pfizer's Consumer Health Unit
12:00PM  Tracing Benjamin Graham's Descendants
09:30AM  The Zacks Analyst Blog Highlights: Chevron, Glaxo, Aflac, Novo Nordisk and MGM Resorts
Nov-09-16 12:00PM  Donald Trump Election Victory Boosts Some Stocks and Sectors
Nov-08-16 12:37PM  Better Buy: Amgen Inc. vs. Johnson & Johnson at Motley Fool
08:49AM  US FDA Clears Propeller Integration With GlaxoSmithKline PLC (ADR) (GSK)s Ellipta at Insider Monkey
08:44AM  5 Healthcare Stocks Kahn Brothers Is Bullish On at Insider Monkey
08:04AM  Understanding Pfizers Products with Declining Sales
05:52AM  Drug Prices to Drop Regardless of U.S. Vote Outcome, Witty Says at Bloomberg
Nov-07-16 08:25AM  5 Out-of-Favor Buy-Rated Stocks Yielding 5% or More at 24/7 Wall St.
07:26AM  Ionis (IONS) Q3 Earnings: What's in the Cards for the Stock?
Nov-04-16 08:05AM  How Does Pfizer's Dividend Stack Up? at Motley Fool
08:04AM  How Could a Salix Sale Impact Valeants Financials?
Nov-03-16 01:23PM  European Stocks Mixed on Corporate Earnings, Brexit News
10:04AM  How Tresiba Helps Novo Achieve Its Growth Targets
07:38AM  3 High-Yield Dividend Stocks to Buy in November at Motley Fool
Nov-02-16 10:41PM  Gilead Science - Buy Hepatitis C Get HIV for Free
07:01PM  Kahn Brothers Adds to 4 Holdings in 3rd Quarter
Oct-31-16 07:33AM  4 Healthcare Stocks to Buy With Dividends Yielding More Than 4% at Motley Fool
Oct-28-16 03:02PM  3 Retirement Stocks to Buy in November at Motley Fool
Oct-27-16 02:17PM  Why Fret Over Agenus Inc. Q3 Results? at Motley Fool
11:53AM  Does GlaxoSmithKline's Sales Surge Make It An Unmissable 'Buy'? at Forbes
11:42AM  Glaxo (GSK) Beats Q3 Earnings Estimates, Keeps 2016 View
09:28AM  GSK expands meningitis B vaccine production in Germany
07:26AM  3 Bargain Bin High-Yield Dividend Stocks You've Overlooked This Fall at Motley Fool
04:14AM  Glaxo's Brexit Profit Bounce Shows Why The FTSE 100 Is Strong at Forbes
Oct-26-16 12:14PM  GlaxoSmithKline CEO Touts HIV Medicines, Pipeline
10:28AM  Drugmaker GSK returns to growth in China after torrid time Reuters
10:07AM  British imports of cheap medicines dry up as pound falls Reuters
10:00AM  GlaxoSmithKline PLC (ADR) (GSK) Teams Up With Fimbrion Therapeutics, Inc. at Insider Monkey
09:28AM  [$$] Glaxo Profit Jumps on Weaker Pound at The Wall Street Journal
09:24AM  Glaxo beats 3Q profit forecasts
09:07AM  Glaxo (GSK) Beats Q3 Earnings, Revenues Rise Y/Y
09:02AM  GlaxoSmithKline beats forecasts as weak pound provides windfall Reuters
08:27AM  Better Buy: GlaxoSmithKline plc vs. Eli Lilly and Company at Motley Fool
08:25AM  European Economy Improving Fast: 4 Top Dividend Stocks to Buy Now at 24/7 Wall St.
08:20AM  GSK CEO: Focus on affordable pricing
08:14AM  GlaxoSmithKline Beats Estimates in Strong Third Quarter
08:04AM  Interesting Trend Developing for Pfizers Pneumococcal Franchise
08:03AM  GSK sees earnings rise amid good demand for vaccines
07:07AM  GlaxoSmithKline enjoys big windfall as pound slides Reuters
07:04AM  Glaxos Profit Beats Estimates; Sales of New Products Surge at Bloomberg
07:04AM  Glaxos Earnings Beat Estimates Sales of Newer Products Rise
Oct-25-16 01:04PM  GlaxoSmithKlines 3Q16 Revenues Are Expected to Rise
10:56AM  GlaxoSmithKlines 3Q16 Earnings: What to Expect
08:37AM  Merck Keytruda Gets FDA Approval for First-Line Lung Cancer
03:23AM  [$$] Novartis Profit Helped by GlaxoSmithKline Joint Venture at The Wall Street Journal
Oct-24-16 10:55AM  GlaxoSmithKline seeking U.S. approval for shingles vaccine at bizjournals.com
03:13AM  GSK files potential $1 bln shingles vaccine for U.S. approval Reuters
02:17AM  GSK seeks U.S. approval for shingles vaccine Shingrix Reuters
02:12AM  Glaxo Seeks FDA Approval for Experimental Shingles Vaccine at Bloomberg
Oct-21-16 06:04PM  Do Analysts Expect Negative Growth for Novartis in 3Q16?
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company operates through five segments: Global Pharmaceuticals, HIV, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. It offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. The company also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas under the Sensodyne, Horlicks, Parodontax, Poligrip, Voltaren, Panadol, Otrivin, Tums, Flonase, Eno, and Theraflu brand names. GlaxoSmithKline plc offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and creams. The company has a strategic collaboration with Miltenyi Biotec GmbH to develop a cell and gene therapy automation and processing technology; and a partnership with Fimbrion Therapeutics for the development of a small molecule drug to treat prevent urinary tract infections. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerOct 24Buy14.0066,500931,0003,220,627Oct 26 05:49 PM